Company Directory > Digital Health > Meaningful Insights Biotech Analytics (MiBA)
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Meaningful Insights Biotech Analytics (MiBA) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MiBA is a healthcare AI technology company dedicated to closing the feedback loop between physicians, patients, and industry partners. The company specializes in oncology, providing a platform that integrates real-world data (RWD), genomic information, and clinical trial insights to improve treatment efficacy and accelerate medical research. By leveraging AI-powered analytics, MiBA supports a wide range of stakeholders, including pharmaceutical companies, biotech firms, research organizations, and community oncology practices. Their solutions, such as the MiBA Trials™ platform and Market Basket analytics, help optimize clinical trial design, site selection, and patient identification, ultimately aiming to personalize cancer care and improve patient outcomes.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Oncology AI & Data Analytics
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Caris Life Sciences (Oncology education and quality of care), Guardant Health (Biomarker testing and data analytics), Oncology Consultants (Precision oncology in Houston), AllyGPO (Data-driven insights for community oncology)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Jason Baroff - Managing Partner
Mark Moch - Managing Partner
Seungtaek Lee - VP Health Solutions
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Meaningful Insights Biotech Analytics (MiBA). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.